A systematic review and meta-analysis of diagnostic performance of fluorescein-guided sentinel lymph node biopsy in early breast cancer
Breast Cancer Research and Treatment · 2024-07 · 206 (1) · 19-30
DOI: 10.1007/s10549-024-07310-0 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Breast Cancer Research and Treatment, online erschienen am 26.04.2024. Verfasst von Sanjay Kumar Yadav und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, NSCB Medical College, Jabalpur, India. sky1508@gmail.com. Hauptthemen laut MEDLINE: Sentinel Lymph Node Biopsy, Breast Neoplasms, Fluorescein, Lymphatic Metastasis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Evaluation of axillary lymph nodes status in cN0 axilla is performed by sentinel lymph node biopsy (SLNB) utilizing a combination of radioactive isotope and blue dye or alternative to isotope like Indocyanine green (ICG). Both are very resource-intensive; which has prompted development of low-cost technique of Fluorescein Sodium (FS)-guided SLNB. This systematic review and meta-analysis evaluate the diagnostic performance of FS-guided SLNB in early breast cancer. OBJECTIVES: The objective was to evaluate the diagnostic performance of FS for sentinel lymph node biopsy. METHODS: Eligibility criteria: Studies where SLNB was performed using FS. INFORMATION SOURCES: PubMed, EMBASE, Cochrane library and online clinical trial registers. Risk of bias: Articles were assessed for risk of bias using the QUADAS-2 tool. SYNTHESIS OF RESULTS: The main summary measures were pooled Sentinel Lymph Node Identification Rate (SLN-IR) and pooled False Negative Rate (FNR) using random-effects model. RESULTS: A total of 45 articles were retrieved by the initial systematic search. 7 out of the 45 studies comprising a total of 332 patients were included in the meta-analysis. The pooled SLN-IR was 93.2% (95% confidence interval [CI], 0.87-0.97; 87% to 97%). Five validation studies were included for pooling the false negative rate and included a total of 211 patients. The pooled FNR was 5.6% (95% confidence interval [CI], 2.9-9.07). CONCLUSION: Fluorescein-guided SLNB is a viable option for detection of lymph node metastases in clinically node negative patients with early breast cancer. It achieves a high pooled Sentinel Lymph Node Identification Rate (SLN-IR) of 93% with a false negative rate of 5.6% for the detection of axillary lymph node metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, NSCB Medical College, Jabalpur, India. sky1508@gmail.com.
- Department of Surgery, NSCB Medical College, Jabalpur, India.
- Subharti Institute of Cancer Management & Research, Swami Vivekanand Subharti University Meerut, Meerut, India.
- Department of Surgery (Endocrine Surgery), AIIMS, Patna, India.
- Department of Endocrine Surgery, Sanjay Gandhi Postgraduate Institute Lucknow, Lucknow, India.
- Assistant Professor of Surgery, BP Koirala Institute of Health Sciences Dharan, Dharan, Nepal.
Zitieren
APA
Yadav, S. K., Bharath, S., Sharma, D., Srivastava, A., Jha, C. K., Agarwal, G., Khadka, S., Singh, M., Shekhar, S., & Goyal, A. (2024). A systematic review and meta-analysis of diagnostic performance of fluorescein-guided sentinel lymph node biopsy in early breast cancer. Breast Cancer Research and Treatment, 206(1), 19-30. https://doi.org/10.1007/s10549-024-07310-0
Vancouver
Yadav SK, Bharath S, Sharma D, Srivastava A, Jha CK, Agarwal G, et al. A systematic review and meta-analysis of diagnostic performance of fluorescein-guided sentinel lymph node biopsy in early breast cancer. Breast Cancer Research and Treatment. 2024;206(1):19-30. doi:10.1007/s10549-024-07310-0
BibTeX
@article{Yadav2024,
author = {Yadav, Sanjay Kumar and Bharath, S and Sharma, Dhananjaya and Srivastava, Anurag and Jha, Chandan Kumar and Agarwal, Gaurav and Khadka, Sarada and Singh, Manju and Shekhar, Saket and Goyal, Amit},
title = {A systematic review and meta-analysis of diagnostic performance of fluorescein-guided sentinel lymph node biopsy in early breast cancer},
journal = {Breast Cancer Research and Treatment},
year = {2024},
volume = {206},
number = {1},
pages = {19--30},
doi = {10.1007/s10549-024-07310-0}
}
EUVIMED